Home

Market Capitalization of Glenmark Pharmaceuticals Ltd

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

Market Cap

₹ 62836.24 crore

Last updated on: Jul 17, 2025

Key Highlights

  • The Market Cap of Glenmark Pharmaceuticals Ltd is ₹ 62836 crore as of 17 Jul 25 .
  • The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 2197 as of 18 Jul 14:18 .
  • The dividend payouts of Glenmark Pharmaceuticals Ltd changed from ₹ 2 to ₹ 2.5 over 6 quarters. This represents a CAGR of 16.04% .
Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

Share Price

₹ 2197

-29.65 (-1.33%)

stock direction

Last updated on: Jul 18, 2025

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Jul 20252226.65
16 Jul 20252202.9
15 Jul 20252226.95
14 Jul 20252218.2
11 Jul 20252181.55
10 Jul 20251905.15
09 Jul 20251817.95
08 Jul 20251829.1
07 Jul 20251862.35
04 Jul 20251831.5

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

che

Weakness

2

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Glenmark Pharmaceuticals Ltd

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of Market Cap

Key Valuation Metric of Glenmark Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Glenmark Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Glenmark Pharmaceuticals Ltd

No data available

* All values are in

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
  • The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.

Glenmark Pharmaceuticals Ltd News Hub

Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session

Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1

Read more

21 Aug 24

Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163

Read more

19 Aug 24

Glenmark Pharma gains after American subsidiary launches Olopatadine generic

The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L

Read more

19 Aug 24

Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio

Read more

19 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Glenmark Pharmaceuticals Ltd Market Cap

What is the market cap of Glenmark Pharmaceuticals Ltd?

As of July 18, 2025, Glenmark Pharmaceuticals Ltd has a market capitalization of ₹62836.24, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Glenmark Pharmaceuticals Ltd's market capitalization?

Glenmark Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Glenmark Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Glenmark Pharmaceuticals Ltd's market capitalization change?

Glenmark Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions